Osteoporosis
From the Journals
Risk Assessment Tool Can Help Predict Fractures in Cancer
Researchers collected data on bone mineral density and fractures in 9,877 patients with cancer and 45,875 matched control individuals without...
Latest News
We Asked 7 Doctors: How Do You Get Patients to Exercise?
Make starting easy, recommend doing something they enjoy, point out multiple benefits, and monitor progress.
Latest News
Exercise Plus GLP-1 RAs Upped Weight Loss, Bone Retention
Study finds combination of GLP-1 RAs and exercise increased weight loss and maintained bone health.
Guidelines
USPSTF Draft Recommendations Support More Options for Osteoporosis Screening, Seek More Research in Men
The influential US task force appears likely to largely reiterate recommendations on osteoporosis testing for women, while highlighting the need...
Latest News
Over-the-Counter Arthritis Supplements Pose Adrenal Danger
Patients taking OTC arthritis supplements may need to taper use to avoid adrenal insufficiency, dysfunction, says presenter.
Latest News
‘Don’t Screen’ for Vitamin D: New Endo Society Guideline
Recommendations call for limiting vitamin D in certain groups, and against routine screening in healthy patients.
From the Journals
No Increased Risk for Fractures Seen With Frequent Steroid Injections for Musculoskeletal Conditions
Fracture risk was not associated with the cumulative dose of injected corticosteroids in patients receiving the shots for musculoskeletal pain,...
Latest News
Are Secondary Osteoporosis Causes Under-Investigated?
“An appropriate evaluation for secondary causes of osteoporosis is essential because it impacts different treatment options and modalities.”
Latest News
Anti-Osteoporosis Drugs Found Just as Effective in Seniors
Age is not a significant factor in reducing fracture risk; medications similarly effective in range of ages, finds study.
Latest News
Is It Possible to Reverse Osteoporosis?
Genetics, exercise, and other factors impact bone health in younger years, and therapies may be able to improve or slow osteoporosis.
News from the FDA/CDC
First Denosumab Biosimilar Approved in Two Different Formulations
Denosumab-bddz was also granted interchangeability status, which allows pharmacists to substitute the biosimilar for the reference product without...